Clinical Trials List
Protocol NumberCAL056-102HV
Active
2025-06-30 - 2027-12-31
Phase I
Recruiting1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
80 participants
